The association of Medicare Part D prior authorization for buprenorphine–naloxone with adherence to opioid use disorder treatment guidelines in the United States

• Published in: Addiction (Abingdon, England) Vol. 117; no. 1; pp. 141 - 150
• Main Authors: Parish, William J., Mark, Tami L., Zarkin, Gary A., Weber, Ellen
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01.01.2022
• Subjects: Aged; Analgesics, Opioid - therapeutic use; Authorization; Beneficiaries; Benzodiazepines; Buprenorphine; Buprenorphine - therapeutic use; Buprenorphine, Naloxone Drug Combination - therapeutic use; Cross-Sectional Studies; Diagnosis; Diagnostic tests; Drug addiction; Drug screening; Health insurance; Hepatitis B; HIV; Human immunodeficiency virus; Humans; Induction; Liver; Medical diagnosis; Medical screening; Medicare; Medicare Part D; medication to treat opioid use disorders; Naloxone; Narcotic Antagonists - therapeutic use; Narcotics; Opiate Substitution Treatment; opioid use disorder; Opioid-Related Disorders - drug therapy; Opioids; Patients; Prescription drugs; Prior Authorization; Substance abuse treatment; Substance use disorder; treatment quality; United States; Urine; Visits; United States; United States > US; opioid use disorder; medication to treat opioid use disorders; Buprenorphine; Medicare; treatment quality; prior authorization
• ISSN: 0965-2140; 1360-0443; 1360-0443
• DOI: 10.1111/add.15585

Aims To assess differences in the quality of opioid use disorder (OUD) treatment received by Medicare beneficiaries enrolled in health plans that used prior authorization (PA) for buprenorphine–naloxone compared with those enrolled in plans that did not use PA. Design, Setting and Participants Cross...